Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial
Author(s) Gao C.; Wang R.; van Geuns R.-J.; Tomaniak M.; Takahashi K. et al.
Source Cardiovascular Diabetology; Dec 2020; vol. 19 (no. 1)
Publication Date Dec 2020
Background: Patients with both diabetes mellitus (DM) and chronic kidney disease (CKD) are a subpopulation characterized by ultrahigh ischemic and bleeding risk after percutaneous coronary intervention. There are limited data on the impact of ticagrelor monotherapy among these patients.
The following databases were searched:
EMBASE, MEDLINE, PsycINFO, BNI, CINAHL,
to find ELHT staff publications
Staffed Opening Hours
24/7 access to both libraries is available - please see library staff